Find antibiotic cloxacillin for injection for internal medicine and pediatric care

Strategic Sourcing Guide for Antibiotic Cloxacillin for Injection

Understanding Product Specifications and Physical Attributes

When sourcing antibiotic cloxacillin for injection, buyers must first establish a clear understanding of the physical and chemical specifications that define the product. The core keyword indicates a pharmaceutical-grade injectable antibiotic, which requires precise adherence to state and form requirements. Based on available market data, the product is consistently observed in a solid state, often presented as a powder prior to reconstitution for administration. This powder form is critical for stability and shelf life, necessitating specific storage conditions to maintain efficacy.

The packaging configurations vary significantly across different listings, reflecting the diverse needs of bulk procurement versus clinical distribution. Common packing formats include trays containing 10 or 50 vials per box, as well as individual vials per box. Specific model specifications observed in the market include dosages of 0.25g, 0.5g, and 1.0g per vial. Additionally, some listings specify a volume-based model, such as 1g/7ml, alongside standard weight-based models like 500mg. The physical dimensions of the packaging are also a factor in logistics; standard carton sizes have been noted as 503836 CM, though these dimensions should be verified against specific supplier capabilities to ensure efficient container loading.

Buyers should also note the presence of various chemical classifications in the market data. While the primary focus is on antibiotics, the underlying chemical nature is often categorized under organic or inorganic chemicals, and specifically as chemical synthetic drugs. The CAS numbers associated with this class of compounds, such as 69-52-3 and 7081-44-9, serve as unique identifiers for verification. However, procurement professionals must exercise caution, as the presence of multiple CAS numbers in general listings may indicate a broader range of chemical products rather than a single specific formulation. The primary application is internal medicine, with a specific usage mode designated for injection. This distinction is vital, as the product is not intended for oral administration, despite the existence of capsule forms for other antibiotic classes in the general market.

Compliance, Certification, and Quality Standards

In the pharmaceutical sector, compliance is not merely a regulatory formality but a fundamental prerequisite for product safety and efficacy. For antibiotic cloxacillin for injection, the verification of manufacturing standards is paramount. The market data indicates that suppliers may hold GMP (Good Manufacturing Practice) certification, and specific listings explicitly state "Factory Certified: GMP" and "GMP: Yes." This certification ensures that the production facility adheres to strict quality control procedures regarding hygiene, equipment maintenance, and process validation.

Beyond GMP, buyers must scrutinize the quality standards applied to the final product. Observed standards in the supply chain include references to USP (United States Pharmacopeia) and BP (British Pharmacopoeia). These are globally recognized benchmarks for purity, potency, and safety. However, the data also lists "as buyer's request" as a standard, which implies a potential for customization but also necessitates rigorous contract negotiation to ensure that the agreed-upon standard is legally binding and enforceable. Other observed standards include specific packaging counts like "10 vials" or "50 vials/box," which serve as logistical standards rather than quality metrics.

The origin of the product is another critical compliance factor. The majority of the observed supply originates from China, with specific mentions of regions such as Jiangsu, Shaanxi, and Beijing. One specific listing references "China Reyoung," which may indicate a specific manufacturer or trading entity, but buyers should not assume this is the sole source. The geographic concentration in these regions suggests a mature pharmaceutical manufacturing ecosystem, yet it requires due diligence to verify the specific factory's license and audit history.

Furthermore, the product is classified under "Biological Products" in some contexts, while others list it as "Organic Chemicals" or "Inorganic Chemicals." This inconsistency in classification highlights the need for buyers to request detailed product monographs that clearly define the chemical structure and biological activity. The storage method is also a compliance issue; the product requires "Light Proof" storage, which must be maintained throughout the supply chain to prevent degradation. Failure to adhere to these storage and certification requirements can lead to product spoilage and regulatory rejection.

Cost Drivers and Pricing Dynamics

The pricing structure for antibiotic cloxacillin for injection is influenced by a complex interplay of factors, including dosage, packaging, order volume, and supply chain logistics. The observed price range in the market is notably low, spanning from 0 to 6 USD. This wide and seemingly anomalous range suggests that the listed prices may represent unit costs for very small quantities, promotional offers, or potentially incomplete data points that do not reflect the true cost of bulk procurement. Buyers should treat these figures as indicative of a low-cost market segment rather than a definitive price list.

The Minimum Order Quantity (MOQ) is a significant driver of unit cost. The observed MOQ range is vast, extending from 1 unit to 1,000,000 units. This indicates that the market accommodates both small-scale clinical trials and massive industrial distribution. For buyers seeking the lowest unit price, negotiating a higher MOQ is essential. The data suggests that "Bulk" is a common quantity descriptor, implying that economies of scale are a primary mechanism for cost reduction. However, the specific price per unit for bulk orders is not explicitly defined in the provided facts, requiring direct negotiation with suppliers.

Packaging costs also play a role in the final price. Different packaging configurations, such as 10 vials per tray versus 50 vials per tray, may incur different handling and material costs. Additionally, the customization of packaging, which is listed as "Available," can add to the expense. Buyers must balance the cost of custom designs against the logistical benefits of standardized packaging. The "Design" customization option suggests that branding and labeling can be tailored, which is a value-add for distributors but may carry a premium.

Other cost drivers include the origin of the product and the associated shipping logistics. Sourcing from regions like Jiangsu, Shaanxi, or Beijing may offer competitive manufacturing costs, but freight charges to international markets, particularly to regions like Africa as noted in the market data, will impact the landed cost. The "Combined Medication" pharmacodynamic factor also suggests that the product may be part of a larger treatment regimen, which could influence the overall procurement strategy and budget allocation.

Typical Applications and Clinical Usage

The primary application of antibiotic cloxacillin for injection is in the field of internal medicine, specifically for the treatment of bacterial infections. The product is designed for injection, a route of administration that ensures rapid and complete bioavailability, which is crucial for treating serious infections. The target demographic for this product includes adults, children, and the elderly, indicating a broad clinical utility across different age groups. This versatility makes it a valuable asset for hospitals and clinics serving diverse patient populations.

The specific clinical use cases often involve the prevention and treatment of parasite diseases, as indicated by the "Parasite Disease Prevention Medicine" classification in some market listings. However, this classification should be verified against the specific pharmacological profile of cloxacillin, which is primarily an antibiotic targeting bacterial infections, particularly those caused by penicillinase-producing staphylococci. The "Pharmacodynamic Influential Factors" note regarding "Combined Medication" suggests that the drug is often used in conjunction with other therapies to enhance efficacy or manage resistance.

The product's state as a solid powder requires reconstitution before administration. This process is a critical step in the clinical setting, as improper reconstitution can lead to dosing errors or reduced efficacy. The "Usage Mode" is strictly defined as injection, distinguishing it from oral formulations like capsules, which are also observed in the general antibiotic market but are not suitable for this specific injectable product. The "Component" is listed as "Chemical Synthetic Drugs," confirming its man-made origin and the need for precise chemical synthesis to ensure consistency.

Buyers should also consider the storage requirements in their application planning. The "Light Proof" storage method is essential to maintain the stability of the active ingredient. In clinical settings, this means that storage areas must be controlled to prevent exposure to direct sunlight or intense artificial light. The "Email" contact provided in the data, [email protected], may be a point of contact for technical inquiries regarding usage and handling, though buyers should verify the authenticity of such contacts before sharing sensitive information.

Supplier Evaluation and Market Verification

Evaluating suppliers for antibiotic cloxacillin for injection requires a multi-faceted approach that goes beyond simple price comparison. The market data reveals a concentration of suppliers in China, with specific mentions of regions like Jiangsu, Shaanxi, and Beijing. While this geographic clustering suggests a robust supply chain, it also necessitates rigorous due diligence to ensure the legitimacy and reliability of the suppliers. Buyers should verify the "Factory Certified: GMP" status through independent audits or third-party verification services, as self-reported certifications can be misleading.

The "Customization" availability is a key differentiator among suppliers. Some suppliers offer design customization for packaging and labeling, which can be crucial for distributors looking to brand products for specific markets. However, the ability to customize does not guarantee the quality of the underlying product. Buyers must assess the supplier's capacity to maintain quality standards while accommodating custom requests. The "Quantity: Bulk" descriptor suggests that suppliers are capable of handling large orders, but the specific lead times and production capacity should be confirmed through direct communication.

The "Market" data indicates a focus on the African region, which implies that some suppliers have experience navigating the regulatory and logistical challenges of that market. This experience can be a valuable asset for buyers targeting similar regions. However, the "Standard" of "503836 CM" and "10 vials" are logistical specifications that should be verified against the actual product dimensions to ensure compatibility with shipping containers and storage facilities.

Buyers should also be wary of inconsistent product classifications. The presence of "Organic Chemicals," "Inorganic Chemicals," and "Biological Products" in the same dataset suggests a lack of standardization in how suppliers list their products. This inconsistency highlights the need for buyers to request detailed product specifications and certificates of analysis (CoA) to confirm the exact nature of the product being offered. The "CAS" numbers provided, such as 69-52-3 and 7081-44-9, should be cross-referenced with the product's chemical structure to ensure accuracy.

Quality Control and Long-Term Procurement Strategy

Maintaining high quality in the procurement of antibiotic cloxacillin for injection requires a proactive approach to quality control. The "Quality Standard" of USP and BP provides a baseline for purity and potency, but buyers should also demand batch-specific testing results. The "Standard" of "as buyer's request" indicates flexibility, but this flexibility must be balanced with strict quality agreements to prevent the acceptance of substandard products. The "Storage Method" of "Light Proof" must be enforced throughout the supply chain, from the factory to the final point of use.

Long-term procurement strategies should focus on building relationships with suppliers who demonstrate consistent quality and reliability. The "Customization" and "Design" options suggest that suppliers are willing to adapt to buyer needs, which can lead to more stable and predictable supply chains. However, buyers should establish clear contractual terms regarding quality assurance, including the right to audit the supplier's facilities and the requirement for regular quality reports.

The "Pharmacodynamic Influential Factors" of "Combined Medication" suggest that the product is part of a broader treatment protocol. This context should be considered when planning long-term procurement, as the demand for the product may fluctuate based on the prevalence of specific diseases and the availability of alternative treatments. The "Varieties" listed as "Parasite Disease Prevention Medicine" may also influence demand patterns, particularly in regions where such diseases are endemic.

Finally, buyers should monitor the "Market" trends, particularly in regions like Africa, to anticipate changes in demand and supply. The "Quantity: Bulk" nature of the market suggests that large-scale procurement is common, and buyers should plan for the logistical challenges associated with bulk orders. By combining rigorous quality control with strategic supplier evaluation, buyers can ensure a steady supply of high-quality antibiotic cloxacillin for injection that meets the needs of their patients and regulatory bodies.

Comparative Analysis of Product Attributes

To facilitate informed decision-making, the following table summarizes the key attributes observed in the market for antibiotic cloxacillin for injection. This comparison highlights the variability in specifications and the need for careful verification.

This table underscores the importance of verifying each attribute against the specific needs of the buyer. The presence of conflicting data, such as "Injection" versus "For oral administration," necessitates a thorough review of product documentation to avoid procurement errors. By adhering to these verification steps, buyers can mitigate risks and ensure the acquisition of high-quality antibiotic cloxacillin for injection.